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By mutating the target residue of covalent flavinyla-
tion in vanillyl-alcohol oxidase, the functional role of
the histidyl-FAD bond was studied. Three His422 mu-
tants (H422A, H422T, and H422C) were purified, which
all contained tightly but noncovalently bound FAD.
Steady state kinetics revealed that the mutants have
retained enzyme activity, although the turnover rates
have decreased by 1 order of magnitude. Stopped-flow
analysis showed that the H422A mutant is still able to
form a stable binary complex of reduced enzyme and a
quinone methide product intermediate, a crucial step
during vanillyl-alcohol oxidase-mediated catalysis. The
only significant change in the catalytic cycle of the
H422A mutant is a marked decrease in reduction rate.
Redox potentials of both wild type and H422A vanillyl-
alcohol oxidase have been determined. During reduc-
tion of H422A, a large portion of the neutral flavin
semiquinone is observed. Using suitable reference dyes,
the redox potentials for the two one-electron couples
have been determined: 217 and 2113 mV. Reduction of
wild type enzyme did not result in any formation of
flavin semiquinone and revealed a remarkably high re-
dox potential of 155 mV. The marked decrease in redox
potential caused by the missing covalent histidyl-FAD
bond is reflected in the reduced rate of substrate-medi-
ated flavin reduction limiting the turnover rate.
Elucidation of the crystal structure of the H422A mu-
tant established that deletion of the histidyl-FAD bond
did not result in any significant structural changes.
These results clearly indicate that covalent interaction
of the isoalloxazine ring with the protein moiety can
markedly increase the redox potential of the flavin co-
factor, thereby facilitating redox catalysis. Thus, forma-
tion of a histidyl-FAD bond in specific flavoenzymes
might have evolved as a way to contribute to the en-
hancement of their oxidative power.
Until now, several hundred flavin-containing enzymes have
been described. Most of these enzymes contain a dissociable
FAD or FMN cofactor. However, it has been shown that in
several cases the flavin is covalently linked to an amino acid of
the polypeptide chain. In fact, in humans 10% of the cellular
FAD is covalently bound to enzymes like e.g. succinate dehy-
drogenase and monoamine oxidase (1). Within the group of
covalent flavoproteins, five different types of covalent flaviny-
lation have been identified. Except for a few examples of cys-
teinyl- or tyrosyl-linked flavins, tethering to a histidine is by
far the most favored binding mode, since it has been observed
in about 20 isolated flavoenzymes (for a recent review, see
Ref. 2).
Although the first covalent flavoprotein, succinate dehydro-
genase, was already identified in 1955 (3), the rationale for
covalent flavinylation is still unresolved. Only recently, a clear
influence of the covalent bond on the reactivity of the cofactor
has been observed in trimethylamine dehydrogenase. Unlike
the wild type enzyme, mutants of trimethylamine dehydrogen-
ase containing dissociable FMN (4, 5) are inactivated by hy-
droxylation of the cofactor. Apparently, covalent tethering of
the cofactor can prevent inactivation of the cofactor. Another
striking role of the covalent flavin bond has been suggested for
p-cresol methylhydroxylase. Inspection of the crystal structure
of this flavocytochrome indicates that the tyrosyl-FAD bond
facilitates electron transfer from the reduced FAD to the heme
of the cytochrome c subunit (6). It has also been shown that
introduction of a covalent bond at the 8a-position of the
isoalloxazine ring can result in an increase of the redox poten-
tial (7–9). A reduced oxidative activity of mutants of succinate
dehydrogenase and fumarate dehydrogenase was rationalized
by a decrease of the flavin redox potential due to the missing
covalent bond (10–12).
Although the above mentioned results indicate that covalent
flavinylation might be advantageous for catalysis, it should be
mentioned that several covalent flavoenzymes have homolo-
gous flavin-dissociable counterparts that display similar en-
zyme activities (13–15). Therefore, the rationale for this atyp-
ical protein modification might not be uniform, and also other
factors may have attributed to the formation and conservation
of covalent flavoproteins throughout evolution. For example,
covalent binding of flavins can be favorable for flavoenzymes
that are localized in a flavin-deficient environment. In this
respect, it is noteworthy to mention that almost all eucaryotic
covalent flavoproteins have been found to be compartmental-
ized (16). Therefore, the motive for covalent flavinylation might
also reside in the physiological function and environment of
these flavoenzymes. Further, covalent flavinylation can also be
of structural benefit. Except for cofactor saturation of the active
site, the introduction of a covalent flavin-protein bond may well
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result in an improved protein stability.
In this study, we have addressed the function of covalent
flavinylation in vanillyl-alcohol oxidase (VAO),1 which is a
covalent flavoprotein containing 8a-(N3-histidyl)-FAD (17).
VAO is a fungal enzyme of 560 residues that can efficiently
oxidize a broad range of phenolic compounds (18, 19). Kinetic
analysis of the conversion of the physiological substrate 4-(me-
thoxymethyl)phenol has revealed that the enzyme operates in
a ternary complex mechanism (20) (Scheme 1).
During the first half-reaction, the substrate reduces the fla-
vin cofactor, resulting in the formation of a stable binary com-
plex of reduced enzyme and a p-quinone methide intermediate
of the substrate. Subsequent reoxidation of the cofactor by
molecular oxygen completes the catalytic cycle, yielding the
final products and oxidized enzyme.
Recently, we have solved the crystal structure of VAO (21),
representing the first crystal structure of a flavoenzyme with a
histidyl-bound FAD. The VAO monomer comprises two do-
mains, with the larger domain forming a FAD binding module
while the cap domain, containing the histidine linking the
FAD, covers the active site (Fig. 1). By sequence homology
analysis and inspection of the crystal structure of VAO, we
have identified a novel flavoprotein family sharing a conserved
FAD binding domain (22). Members of this family that have
been characterized catalyze a variety of oxidation/reduction
reactions and include several well studied covalent flavopro-
teins: e.g. 6-hydroxy-D-nicotine oxidase (23), p-cresol methylhy-
droxylase (6), and L-gulono-g-lactone oxidase (24). Interest-
ingly, in about 35% of the sequences of these VAO homologs, a
conserved histidine residue is found, which is predicted to be
flavinylated (22). Apparently, covalent flavinylation within
this flavoprotein family is a relatively frequent event, indicat-
ing that the conserved topology is particularly suited for cova-
lent flavinylation or that this flavoprotein family originates
from an ancestral covalent flavoprotein.
To study the effect of covalent flavinylation on the structural
and kinetic properties of VAO, we have mutated the target
residue for flavinylation, His422, thereby preventing formation
of the histidyl-FAD bond. Here we present the crystal structure
of the H422A mutant containing a dissociable FAD. Further-
more, the effects of the covalent bond deletion on the kinetic
and redox properties of VAO are discussed.
EXPERIMENTAL PROCEDURES
Materials—Escherichia coli strain DH5aF9 (25) and the plasmids
pUCBM20 (Roche Molecular Biochemicals) and pGEM-5Zf(1) (Pro-
mega) were used for cloning, whereas E. coli strain TG2 (26) and the
plasmid pEMBL19(2) (Roche Molecular Biochemicals) were used for
expression of the vaoA gene. T4 DNA ligase, restriction enzymes, iso-
propyl-b-D-thiogalactopyranoside, yeast extract, and tryptone extract
were from Life Technologies, Inc. Pwo DNA polymerase and dNTPs
were purchased from Roche Molecular Biochemicals, and Super Taq
DNA polymerase was from HT Biotechnology. Ampicillin and SDS were
from BDH Chemicals. Forward M13 and reverse M13 sequencing prim-
ers were from Amersham Pharmacia Biotech. Oligonucleotides were
synthesized by Life Technologies.
Glucose oxidase was from Roche Molecular Biochemicals, and benzyl
viologen, indigo disulfonate, indigo tetrasulfonate, methylene blue, xan-
thine, and xanthine oxidase were from Sigma. Resorufin, isoeugenol,
and 4-(methoxymethyl)phenol were products from Aldrich, and thionin
was from Eastman Kodak Co. All other chemicals were from Merck and
of the purest grade available.
Mutagenesis—To simplify the site-directed mutagenesis procedure, a
SalI restriction site was created by a silent mutation at position 882 in
the original expression plasmid pIM3972 (27). For this, the NcoI–NsiI
fragment of pIM3972 was ligated into pGEM-5Zf(1). Subsequently, the
silent mutation was introduced by polymerase chain reaction-based
mutagenesis using the oligonucleotide 59-CAAGCCGTCGACATTAT-
TCGTCC-39 (where C denotes the mutated base). The mutated NcoI–
NsiI fragment was ligated into pIM3972. The resulting pBC11 plasmid
was used for polymerase chain reaction-based mutagenesis. For the
His422 replacements, the SalI–KpnI fragment of pBC11 was ligated into
pUCBM20. This construct was used for polymerase chain reaction-
based mutagenesis with the oligonucleotide 59-CCCTAATGGTGCGXX-
TCTGTTCTTCTCTCC-39 (where XX denotes the replacement for GC
(H422A), AC (H422T), and TG (H422C), respectively). The mutated
SalI–KpnI fragments were ligated into pBC11, yielding pBC20
(H422A), pBC21 (H422T), and pBC22 (H422C). Successful mutagenesis
was confirmed by plasmid sequencing.
Analytical Methods—Mutant proteins were expressed and purified
as described for wild type VAO (27). SDS-polyacrylamide gel electro-
phoresis was carried out according to Laemmli (28). Protein staining of
the gels was achieved using Coomassie Brilliant Blue R-250, while
histidyl-FAD fluorescence was detected as described earlier (29). Ana-
lytical gel filtration was performed on a Superdex 200 HR 10/30 column
using an A¨kta system (Amersham Pharmacia Biotech) under conditions
described elsewhere (30).
All analytical experiments were performed at 25 °C in 50 mM potas-
sium phosphate buffer, pH 7.5. Flavin absorption spectra were recorded
on an automated Aminco DW-2000 spectrophotometer. Flavin fluores-
cence emission spectra (excitation at 450 nm) were obtained using an
Aminco SPF-500 fluorometer. Redox potentials were determined by the
method described by Massey (31). For this, a cuvette containing enzyme
(2–12 mM), benzyl viologen (2.0 mM), redox dye (2–10 mM), and xanthine
(400 mM) was made anaerobic by flushing with argon, after which
0.2–0.5 nM xanthine oxidase was added (total volume was 750 ml). To
maintain anaerobic conditions during the reductive titration, the head
space of the septum-closed cuvette was continuously flushed with ar-
gon. During the xanthine oxidase-mediated reduction (lasting typically
1–2 h), spectra were recorded automatically every 30 s using a Hewlett-
Packard 8453A diode array spectrophotometer.
Steady state kinetic experiments were performed as described earlier
(18). Stopped-flow kinetics were carried out with a Hi-Tech SF-51
apparatus equipped with a Hi-Tech M300 monochromator diode-array1 The abbreviation used is: VAO, vanillyl-alcohol oxidase.
SCHEME 1
FIG. 1. Ribbon representation of a vanillyl-alcohol oxidase
monomer. The histidyl-bound FAD cofactor is shown in a ball-and-
stick model. This figure was prepared with MOLSCRIPT (55).
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detector (Salisbury, United Kingdom) as described previously (20). De-
convolution of spectral data was performed using the Specfit Global
Analysis program version 2.10 (Spectrum Software Associates, Chapel
Hill, NC).
Crystallization, Data Collection, and Processing—Bright yellow crys-
tals of all His422 mutants were obtained using the hanging drop vapor
diffusion method at similar conditions (5% (w/v) polyethylene glycol
4000, 100 mM sodium acetate/HCl, pH 5.1) that were used for crystal-
lizing wild type VAO (32). Crystallization of H422A resulted in the most
regularly shaped crystals. The crystal structure of H422A was deter-
mined in the absence and presence of the substrate analog isoeugenol
using crystals of about 0.2 3 0.2 3 0.3 mm3. Binding of isoeugenol was
achieved by soaking the crystal for 3 h in a solution containing a 1 mM
concentration of the inhibitor.
Data sets were collected at the x-ray diffraction beam line of ELET-
TRA (Trieste, Italy) at 100 K. Before freezing, the crystals were briefly
transferred to a solution containing 20% (w/v) polyethylene glycol 400,
5% (w/v) polyethylene glycol 4000, 20% (v/v) glycerol, and 100 mM
acetate/HCl, pH 5.1. A complete data set was collected at 100 K using a
single crystal. The data were processed using MOSFLM (written by
A. G. W. Leslie). Crystals of the H422A mutant were isomorphous to
those of wild type enzyme, and they belong to space group I4. Crystal-
lographic refinement was performed with the REFMAC program (33). A
bulk solvent correction was applied using programs of the CCP4 pro-
gram package (34). Model building was carried out using the program O
(35), whereas positions of ordered water were identified using the ARP
program (36). The free R-factor was calculated employing the same
reflections used for the free R-factor calculations in the refinement of
the wild type structure (21). The free R-factor was used to monitor the
progress of refinement. Table II gives a summary of the final refinement
statistics.
RESULTS
Purification and General Characterization—The three
His422 mutant enzymes were purified using the same protocol
as has been developed for wild type VAO, resulting in bright
yellow protein preparations. SDS-polyacrylamide gel electro-
phoresis combined with protein staining showed that all three
mutant preparations contained protein with a molecular
weight similar to that of wild type VAO. Further, fluorescence
analysis of the same gel revealed that the His422 mutants do
not contain covalent histidyl-FAD, since, in contrast to the wild
type enzyme, no flavin fluorescence could be observed. This
finding was confirmed by precipitating the mutant enzymes
with 5% trichloroacetic acid, resulting in a yellow supernatant
containing FAD and a colorless pellet of aggregated protein.
Treating wild type VAO in the same way resulted in a colorless
supernatant, while a yellow pellet was formed (17).
Analytical gel filtration experiments showed that the His422
mutants are mainly in the octameric form with a small portion
being present as a dimer. By simultaneously monitoring the
absorbance at 280 and 450 nm, the presence of FAD in both
oligomeric forms could be demonstrated. In both the octameric
and dimeric state, the ratio of protein (280 nm) absorbance and
flavin (450 nm) absorbance was identical. These results indi-
cate that the purified mutants display a similar oligomeriza-
tion behavior with respect to wild type VAO (30).
Spectral Properties—The ratio of absorbance between 280
and 439 nm for all mutants was 11.5, which is similar to the
value reported for wild type VAO (17). Further, the flavin
absorption spectra of all three mutants were virtually identical
with maxima at 390 and 439 nm (Fig. 2). When comparing the
flavin spectra of the mutants and wild type enzyme, it can be
clearly seen that the spectral characteristics at lower wave-
lengths have drastically changed, while the spectral character-
istics at around 439 nm are hardly affected by the mutation.
These results are in line with the fact that the mutants do not
form a covalent FAD bond, since 8a-substituted histidyl-FAD
can be identified by a typical hypsochromic shift of the near-UV
absorbance maximum with respect to unmodified FAD (37). In
addition to histidyl-FAD, cysteinyl-bound FAD has been ob-
served in several covalent flavoproteins (2). The observation
that the H422C mutant does not contain any detectable cova-
lent FAD indicates that formation of the covalent histidyl-FAD
linkage in VAO is a very specific mechanism. Further, although
the mutations prevent covalent linkage of FAD, all mutants
contain tightly bound FAD, since they were purified in the holo
form. Attempts to generate apoenzyme using established meth-
ods (38) failed. The noncovalent His422 mutants displayed sim-
ilar flavin fuorescence properties when compared with wild
type VAO. When exciting at 450 nm, emission fluorescence
spectra were observed with maxima at 535 nm. Similar to wild
type VAO, the flavin fluorescence quantum yields were very
low, indicating that the covalent histidyl-FAD bond is not a
major factor in flavin fluorescence quenching in VAO. From
these experiments, it can also be concluded that the His422
mutants have a high affinity for FAD, since no significant
amounts of free FAD could be detected. These results indicate
that the covalent histidyl-FAD bond is not essential for FAD
binding.
Kinetic Characterization—To examine the effect of the mu-
tations on enzyme kinetics, the steady state kinetic parameters
were determined using 4-(methoxymethyl)phenol as substrate
(Table I). It was revealed that all purified mutants display
significant enzyme activity. The kcat values of the three mu-
tants decreased by about 1 order of magnitude, while the Km
values were significantly lower with respect to wild type en-
zyme. In contrast to observations with some other mutated
covalent flavoenzymes (5, 39, 40), the activity remained con-
stant during prolonged incubations (10 min) with substrate.
This indicates that the FAD cofactor remains bound to the
enzyme and is not inactivated during catalysis. Since all three
mutants showed similar spectral and steady state kinetic prop-
erties, we decided to perform a more detailed study of the
H422A mutant.
The apparent increased affinity for phenolic ligands was
studied in some more detail by determining the dissociation
constant for the competitive inhibitor isoeugenol. Titration ex-
periments with the H422A mutant revealed that the dissocia-
tion constant for isoeugenol was also significantly lower when
compared with the corresponding Kd value for wild type en-
zyme (18): 4.6 versus 22 mM.
To identify the rate-limiting step in catalysis by the H422A
mutant, stopped-flow experiments were performed. For this,
the kinetics of the individual half-reactions were studied. The
reductive half-reaction of H422A appeared to be a monophasic
process as has been found for wild type VAO (Fig. 3). Anaerobic
reduction by 4-(methoxymethyl)phenol resulted in fully re-
duced enzyme as monitored by the absorbance decrease at 439
nm. This indicates that, as in wild type enzyme, the substrate-
FIG. 2. Flavin absorption spectra of 10 mM wild type VAO
(dashed line) and the H422A mutant (solid line) in 50 mM potas-
sium phosphate, pH 7.5.
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induced reduction of the flavin cofactor is an irreversible proc-
ess (41). The maximal reduction rate of 0.30 s21 approaches the
maximal turnover rate, indicating that the rate of turnover is
mainly determined by the rate of flavin reduction. This finding
was confirmed by an enzyme-monitored turnover experiment
that showed that, during turnover, more than 90% of H422A is
in the oxidized state. In line with the decreased Km value, it
was found that the dissociation constant for 4-(methoxymeth-
yl)phenol is also relatively low (Table I). Furthermore, by using
diode-array detection, it could be shown that upon anaerobic
reduction with 4-(methoxymethyl)phenol, H422A is able to
form and stabilize a binary complex between reduced enzyme
and the p-quinone methide product intermediate. Decay of this
complex, resulting in formation of 4-hydroxybenzaldehyde, was
only observed when the anaerobic reduction reaction was mon-
itored for a relatively long period of time (.10 s) (see Fig. 3,
inset). Apparently, the mutant enzyme has still retained the
remarkable ability to shield the formed quinone methide inter-
mediate from solvent (20). Upon reoxidation of the reduced
complex by molecular oxygen, the quinone methide intermedi-
ate was efficiently hydrated as has been found for the wild type
enzyme. Analysis of the oxidative half-reaction showed that the
rate of reoxidation of the binary complex is also similar to that
of the wild type enzyme (Table I). From these kinetic measure-
ments it can be concluded that except for a decrease in the rate
of flavin reduction, the catalytic mechanism by which substrate
is converted has essentially been conserved in the H422A
mutant.
Redox Potential Determination—For both wild type VAO and
the H422A mutant, the flavin redox potential was determined
using the method described by Massey (31) (see “Experimental
Procedures”). When the xanthine oxidase-mediated reduction
of the mutant was monitored in the absence of a reference dye,
the initial formation of a one-electron-reduced flavin species
was observed (Fig. 4). Based on the typical absorbance proper-
ties in the 500–600-nm region, the radical intermediate could
be identified as the blue neutral flavin semiquinone (42, 43).
Previously, it has been observed that in wild type VAO the red
anionic flavin radical is transiently formed upon light-induced
reduction (17). Apparently, the H422A mutation results in an
increase of the pKa of the one-electron-reduced form of the
flavin cofactor in VAO. Such a pKa shift of the flavin semiqui-
none has also been observed in flash photolysis studies on
8a-histidyl flavins (44). From estimation of the maximal
amount of flavin radical formed during the reduction process
(70–75%) (see Fig. 4, inset), it can be deduced that the redox
potentials for the oxidized/semiquinone couple (E1) and the
semiquinone/hydroquinone couple (E2) are separated by about
85 6 7 mV (45). By using methylene blue (111 mV) and indigo
disulfonate (2118 mV) as reference dyes, the two redox poten-
tials could be accurately determined. The redox potential dif-
ference with respect to the dye could be calculated by plotting
the log([ox]/[red]) ratio of the enzyme versus the corresponding
log([ox]/[red]) ratio of the dye (46). The slopes for the two
respective plots were 0.52 and 0.55, approaching the theoreti-
cal value of 0.5, indicating that equilibrium between the redox
components during the reduction experiment was established.
The two redox potentials E1 and E2 were 217 and 2113 mV,
respectively. These values are in line with the above mentioned
estimated separation of the two redox potentials. Furthermore,
the data obtained by reducing the mutant in the presence of
resorufin (251 mV) also corroborated with these results. Re-
duction of this dye only occurred after formation of flavin
semiquinone, while full reduction of the flavin only started
when most of the dye was already reduced. The midpoint redox
potential (Em) of H422A is 265 mV (Em 5 (E1 1 E2)/2; see Ref.
45). The Em of wild type VAO could be similarly determined by
using thionin (160 mV) as reference dye. In contrast with
H422A, the reduction of wild type VAO did not result in any
observable formation of a radical species. Plotting the data
according to Minnaert (46) resulted in a slope of 0.97, which is
close to the theoretical value of 1.0 for a two-electron reduction
process and a midpoint redox potential of 155 mV. The Em for
wild type enzyme (155 mV) is markedly higher when compared
with the Em for the H422A mutant (265 mV). This indicates
that the histidyl-FAD covalent bond together with specific non-
covalent cofactor-protein interactions results in an exceptional
high Em that is about 250 mV higher than the Em of free FAD
(31). To our best knowledge, only one other example of a fla-
voenzyme exhibiting an equally high Em (155 mV) has been
reported, thiamine oxidase (47). Interestingly, this bacterial
enzyme also contains a histidyl-bound FAD.
Structure of H422A—The crystal structure of unliganded
H422A was determined at 2.2 Å (Table II). The resolution
obtained for the mutant structure is an improvement when
compared with the originally determined structure of wild type
VAO (2.5 Å) (21). The x-ray analysis clearly shows that there is
no covalent bond between the FAD cofactor and any residue of
the polypeptide chain. A comparison between the mutant and
the wild type models showed that the H422A replacement did
not cause any large conformational change. Superposition of
the two structures produced a root mean square deviation for
all C-a atoms of only 0.27 Å. Particularly, as in the wild type
structure, the flavin ring is fully planar, and, except for the
covalent bond, all other interactions with the isoalloxazine ring
are conserved. The position of the C-a atom of Ala422 did not
TABLE I
Kinetic constants for the reaction of the His422 mutants and wild type
VAO with 4-(methoxymethyl)phenol (pH 7.5, 25 °C)
Parameter Wild typea H422A H422C H422T
Km (mM) 55 34 37 41
kcat (s
21) 3.1 0.27 0.32 0.28
Kd (mM) 48 18 ND
b ND
kred (s
21) 3.3 0.30 ND ND
kox (M
21 s21) 1.5 3 105 2.5 3 105 ND ND
a Data taken from Ref. 20.
b ND, not determined.
FIG. 3. Spectral changes observed upon anaerobic reaction of
H422A (4.0 mM) with 4-(methoxymethyl)phenol (500 mM, 25 °C, pH
7.5). Original spectra are shown from 5.6 ms to 10 s with intervals of
1 s. The inset shows normalized spectra obtained after deconvolution of
the original 96 spectral scans ranging from 5.6 ms to 20 s, where A
represents the initial spectrum, spectrum B the intermediate species,
and spectrum C the finally obtained spectrum at indefinite time. The
data were fit with a consecutive irreversible model (A 3 B 3 C).
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change significantly, resulting in a distance between the C-8
methyl group of the flavin and the C-b atom of Ala422 of 5.3 Å.
Further, all active site residues appear to have essentially
retained their positions (Fig. 5), and, as in the wild type en-
zyme structure, an acetate molecule is found in the active site.
The largest variations concern residues 410–417, which inter-
act with the edge of the dimethylbenzene moiety of the flavin.
The largest movement is that of C-d1 of Ile414 (1.3 Å), although
all other atomic shifts in these residues do not exceed 1.0 Å.
Movements of these atoms accommodate the missing side chain
of His422. Furthermore, the imidazole ring of His61 rotates by
about 50°, pointing to the C-8a methyl group of the flavin ring.
The crystal structure of the H422A mutant in complex with
isoeugenol was determined at 2.4 Å. The crystal soaked with
isoeugenol shows clear density for the substrate analog
isoeugenol in proximity of the flavin ring. The two structures of
the H422A mutant are virtually identical, as indicated by a
root mean square deviation of 0.13 Å for all C-a atoms. The
deletion of the covalent histidyl-FAD bond does not result in
any evident structural perturbations upon ligand binding,
which could explain the reduced enzyme activity of the H422A
mutant. Further, the H422A-isoeugenol complex structure re-
vealed an apparent identical binding mode for the phenolic
inhibitor when compared with the wild type inhibitor complex
structure (21).
DISCUSSION
The results presented in this paper demonstrate that cova-
lent flavinylation is not a prerequisite for efficient FAD binding
in VAO. All three His422 mutants were purified in the holo
form, while no FAD dissociation could be detected in any of the
performed experiments and no influence on the hydrodynamic
properties was observed. These results are perfectly in line
with the determined crystal structure of the H422A mutant.
Analysis of the three-dimensional structure of this noncovalent
FAD containing VAO variant revealed that except for the re-
placement of the histidine no significant structural perturba-
tions can be observed with respect to the wild type VAO struc-
ture (21). From a thorough comparison of the mutant structure
with that of wild type VAO it can be concluded that the two
structures are virtually identical as shown by a root mean
square deviation for all C-a atoms of 0.27 Å. Inspection of the
FIG. 4. Spectral changes during the
anaerobic xanthine oxidase-medi-
ated reduction of 12.0 mM H422A (see
“Experimental Procedures”). Spectra
were obtained at regular time intervals
(12 min), while full reduction was
achieved after 120 min. Inset, by plotting
the absorbance at 520 nm versus the ab-
sorbance at 450 nm, the amount of tran-
siently formed flavin semiquinone can be
estimated (data are shown with 3-min
intervals).
TABLE II
Summary of crystallographic analysis of H422A VAO
H422A H422A with isoeugenol
Resolution (Å) 20–2.2 20–2.4
Observed reflections 285,553 216,054
Unique reflections 55,414 43,343
Completeness of data (%)a 93.1 (78.8) 94.8 (88.4)
Multiplicitya 2.1 (1.8) 2.1 (1.9)
Intensities (I/s)a 6.0 (2.8) 4.9 (2.5)
Rsym (%)
a 8.9 (22.6) 11.9 (32.1)
Cell dimensions (Å) a 5 b 5 129.66, c 5 132.30 a 5 b 5 129.84, c 5 133.90
Rfactor (%) 21.0 21.9
Rfree (%) (2000 reflections) 26.4 27.3
Number of protein atoms 8692 8692
Number of water atoms 373 257
Number of FAD atoms 106 106
Number of ligand atoms 8 (acetate) 22 (isoeugenol)
r.m.s.d. from idealityb
Bond lengths (Å) 0.013 0.012
Bond angles (°) 2.3 2.3
Trigonal groups (Å) 0.023 0.022
Planar groups (Å) 0.011 0.011
Ramachandran plot (%)c 88.3/11.6/0.1/0 89.0/10.8/0.2/0
a The values relating to the highest resolution shell are given in parentheses.
b The root mean square deviations (r.m.s.d.) were calculated using the program REFMAC (33).
c Percentage of residues in most favored, allowed, generously allowed, and disallowed regions of the Ramachandran plot as checked with the
program PROCHECK (54).
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active site also showed that the active site architecture has
been fully conserved. This was confirmed by the crystal struc-
ture of the H422A variant in complex with the substrate analog
isoeugenol. The binding of this phenolic ligand was identical to
the binding mode in wild type enzyme (21). Except for the
deletion of the covalent histidyl-FAD bond, no significant
change in cofactor-protein interactions could be observed. This
clearly indicates that the covalent FAD linkage does not nec-
essarily induce a specific structural feature or is a prerequisite
for proper protein folding. Evidently, the noncovalent interac-
tions of the FAD binding domain in VAO are competent in tight
binding of the cofactor.
Steady state kinetic analysis showed that with respect to
wild type enzyme the turnover rate for all His422 mutants has
markedly decreased (Table I). The stopped-flow technique was
used to identify the reaction step that limits the turnover rate.
Using the H422A mutant, it was found that the rate of flavin
reduction was drastically reduced, while the rate and nature of
the other kinetic processes are almost unaffected by the muta-
tion. Also, enzyme-monitored turnover experiments with the
H422A mutant indicated that the kinetic mechanism is similar
to that of wild type VAO (20). Spectral analysis of the reductive
half-reaction also showed that the mutant is still able to sta-
bilize the p-quinone methide product intermediate. This is
indicative of a conserved active site architecture (Scheme 1),
which was confirmed by the crystal structure. Since the active
site architecture is fully conserved, the decrease in the flavin
reduction rate directly reflects an apparent decrease in flavin
reactivity. Nevertheless, these results also clearly show that
the covalent histidyl-FAD bond in VAO is not a prerequisite for
catalysis, since the His422 mutants still display appreciable
activity.
Determination of the redox potential of several flavin deriv-
atives has revealed that covalent aminoacyl modifications at
the 8a-position of the isoalloxazine ring can result in an in-
crease of the redox potential by 50–60 mV (7, 9). Furthermore,
studies on 8a-N-imidazolylflavins have shown that ionization
of the imidazole substituent can have significant effects on the
flavin redox potential (48). In the H422A mutant, a markedly
lower midpoint redox potential was found when compared with
wild type VAO (265 mV versus 155 mV). As mentioned above,
analysis of the H422A structure shows that the decrease in
midpoint redox potential is not caused by any evident struc-
tural changes but is merely caused by the covalent bond dele-
tion. Apparently, the drastic reduced reactivity of the flavin is
directly reflected in a decreased substrate-mediated flavin re-
duction rate. Further, opposite to wild type VAO, the H422A
mutant displays a significant stabilization of the one-electron-
reduced state. This indicates that the covalent histidyl-FAD
linkage and the resulting interaction with the protein environ-
ment modulates the redox properties of the flavin cofactor in
such a way that it can efficiently be reduced by a direct two-
electron transfer mechanism at a relatively high potential. As
suggested by Parsonage et al. (49), this may well reflect the
ability of the enzyme to be tuned to accept simultaneously two
electrons from the reducing substrate during catalysis, which is
in agreement with the proposed hydride transfer mechanism
(20).
Mutagenesis of the target residue for flavinylation and sub-
sequent kinetic characterization of the resulting mutant pro-
tein has previously been performed with only a few other
covalent flavoenzymes: 6-hydroxy-D-nicotine oxidase (39),
monoamine oxidase A (40), fumarate reductase (10), succinate
dehydrogenase (12), and trimethylamine dehydrogenase (4).
With most of these noncovalent mutant proteins, enzyme ac-
tivity was retained to some extent. Only for succinate dehydro-
genase, it was found that the noncovalent variants had lost the
capacity of oxidizing succinate. In the case of fumarate reduc-
tase and succinate dehydrogenase, the decrease in oxidation
rate of these mutant enzymes was tentatively assigned to the
redox properties of the flavin cofactor (12). However, no com-
parative redox potentials were determined to support this hy-
pothesis. Nevertheless, it is striking to notice that, when com-
paring flavoenzymes of which the redox potential has been
determined, flavoproteins displaying a relatively high redox
potential often contain covalent FAD or FMN. For example, the
covalent flavoenzymes succinate dehydrogenase (50) (23 mV),
trimethylamine dehydrogenase (51) (140 mV), thiamine oxi-
dase (47) (155 mV), and vanillyl-alcohol oxidase (155 mV) all
have redox potentials near the upper limit of redox potentials
that have been determined for flavoprotein oxidoreductases
(52). Apparently, an increase of the flavin redox potential by
covalent flavinylation is a widely used mechanism to enhance
the oxidative power of specific flavoproteins.
Recent studies on trimethylamine dehydrogenase have indi-
cated that covalent bond formation may play a major role in
preventing inactivation of the enzyme by flavin modification
(5). Trimethylamine dehydrogenase mutants, which are unable
to form the 6-S-cysteinyl-FMN bond, readily are inactivated by
hydroxylation of the C-6 of the flavin ring. It was proposed that
this protective effect might also be the rationale for the occur-
rence of 8a-methyl flavinylated enzymes. However, from the
results described in this study, it can be concluded that this
proposed self-protecting function of covalent flavinylation is
not generally valid. Spectral analysis of the VAO mutants
following extensive incubations with or without substrate did
not result in any detection of modified FAD. Further, in all
experiments performed with the mutant enzymes, no apprecia-
ble inactivation could be observed. A plausible reason for the
chemical stability of the isoalloxazine ring in VAO comes from
inspection of the crystal structure. In both the mutant struc-
ture and that of wild type VAO, the benzyl moiety of the
cofactor is found to be protected from solvent, preventing flavin
hydroxylation reactions. Apparently, the susceptibility of flavin
modification within the active site of flavoenzymes is highly
dependent on the active site architecture. This might also hint
at the fact that the evolutionary pressure toward covalent
flavinylation is not necessarily driven by a single specific mo-
tive but can be multifold. However, the recently discovered
FIG. 5. Superposition of active site residues in the unliganded
H422A (shaded) and wild type VAO structures (black). This figure
was prepared with MOLSCRIPT (55).
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flavoprotein family for which VAO is the prototype shows a
relative high frequency of covalent flavinylation via a histidyl
bond (22). Strikingly, all characterized VAO homologs contain-
ing a histidyl-bound FAD represent oxidases, while all nonco-
valent VAO homologs represent dehydrogenases. This suggests
that a relatively high redox potential caused by covalent flavi-
nylation directs the enzyme to accept oxygen as electron accep-
tor as other physiological electron acceptors, e.g. NAD1, have
relatively low redox potentials.
In conclusion, these results clearly show that the covalent
interaction of the isoalloxazine ring with the protein moiety can
markedly increase the redox potential of the flavin cofactor.
This increase in redox potential facilitates redox catalysis by
VAO. From this, it is tempting to conclude that formation of a
histidyl-FAD bond in specific flavoenzymes has evolved as a
way to contribute to the enhancement of their oxidative power.
Moreover, the markedly high redox potential of VAO is a good
illustration of the wide range of redox potentials achieved in
flavin-dependent oxidases, ranging from 2367 mV in nitroal-
kane oxidase (53) to 155 mV in VAO.
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